We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Update on Arrow’s Recall of Intra-Aortic Balloon Pumps
FDA Issues Update on Arrow’s Recall of Intra-Aortic Balloon Pumps
The FDA has identified Arrow International’s Oct. 17 recall of its intra-aortic balloon pumps as Class 1 because the device’s short battery life may cause serious injury or death.